BeOne Medicines (ONC) Prepaid Assets (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Prepaid Assets of $190.0 million for Q1 2026, up 12.97% year-over-year from $168.2 million in Q1 2025, and down 10.7% quarter-over-quarter from $212.8 million in Q4 2025.
BeOne Medicines (ONC) Prepaid Assets (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Prepaid Assets for 12 consecutive years, with $190.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 12.97% year-over-year to $190.0 million; the TTM figure through Mar 2026 stood at $190.0 million (up 12.97% YoY), while the FY2025 annual figure was $212.8 million, up 10.28% from the prior year.
- Prepaid Assets fell to $190.0 million in Q1 2026 per ONC's latest filing, from $212.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.4 billion in Q4 2022 and bottomed at $168.2 million in Q1 2025.
- Historically, Prepaid Assets has averaged $296.4 million across 5 years, with a median of $232.6 million in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 401.27% — and 2023, when it tumbled 80.99%.
- BeOne Medicines' Prepaid Assets stood at $1.4 billion in 2022, then sank by 80.99% to $257.5 million in 2023, then slipped by 25.07% to $192.9 million in 2024, then rose by 10.28% to $212.8 million in 2025, then fell by 10.7% to $190.0 million in 2026.
- Business Quant data shows ONC's Prepaid Assets at $190.0 million in Q1 2026, $212.8 million in Q4 2025, and $232.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 328.98 Mn |
| Mar 31, 2026 | 190.00 Mn |
| Dec 31, 2025 | 212.75 Mn |
| Sep 30, 2025 | 232.64 Mn |
| Jun 30, 2025 | 280.52 Mn |
| Mar 31, 2025 | 168.18 Mn |
| Dec 31, 2024 | 192.92 Mn |
| Sep 30, 2024 | 209.08 Mn |
| Jun 30, 2024 | 273.66 Mn |
| Mar 31, 2024 | 231.74 Mn |
| Dec 31, 2023 | 257.47 Mn |
| Sep 30, 2023 | 241.66 Mn |
| Jun 30, 2023 | 255.05 Mn |
| Mar 31, 2023 | 264.84 Mn |
| Dec 31, 2022 | 1.35 Bn |
| Sep 30, 2022 | 199.77 Mn |
| Jun 30, 2022 | 207.38 Mn |
| Mar 31, 2022 | 266.44 Mn |
| Dec 31, 2021 | 270.17 Mn |
| Sep 30, 2021 | 235.02 Mn |